MAP2K7 and hepatocellular carcinoma: Similarly, the mitogen-activated protein kinase pathway, also known as the RAS/RAF/MEK/extracellular signaling kinase (ERK) (MAPK pathway) was investigated as a potential source of inhibition in advanced HCC given its ubiquitous intracellular signaling transduction role [70].